Labiotech.eu

cardiovascular disease heart attack forcefield therapeutics

News and Trends 25 Apr 2022

Forcefield Therapeutics Launched to Treat Heart Attacks with Protein Drugs

The startup Forcefield Therapeutics has been unveiled in the UK with €6M (£5.5M) backing from the investment firm Syncona. The mission is to develop the first drugs to safeguard heart muscle from damage during heart attacks. A sudden heart attack, also known as acute myocardial infarction, happens when the flow of blood to the heart […]

April 25, 2022 - 4 minutesmins - By Jonathan Smith

Guy Levy Yurista Synthace cloud computing 1

Opinion 25 Apr 2022

Cloud Computing Can Help Life Sciences Catch Up Before It’s Too Late

Biotechnology has the power to tackle global threats such as pandemics and climate change, but antiquated experimental and data collection methods are holding it back. Guy Levy-Yurista, CEO of the experiment platform developer Synthace, explains how cloud computing could accelerate the efforts of biotech companies to solve the big problems. There is a sundial in […]

April 25, 2022 - 5 minutesmins - By External Contributor

News and Trends 22 Apr 2022

European Biotech Investors Brace for Volatility in 2022

After gathering huge investment funds in 2021, European biotech investors took a breather in the first quarter of 2022, with the plan to steadily fund private biotechs amid a tumultuous public market. The last two years have seen a record-breaking amount of money flowing to biotech investors, with almost €10B reaching European life science funders […]

April 22, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 20 Apr 2022

Valneva’s Covid-19 Vaccine Reaches UK Market with EU In Sights

A Covid-19 vaccine developed by the French company Valneva has received the green light from the UK’s drug regulator. The EMA, meanwhile, is proving harder to convince. The UK’s relationship with the French vaccine developer Valneva has run hot and cold over the past two years. In 2020, the UK government invested in Valneva’s manufacturing […]

April 20, 2022 - 4 minutesmins - By Jonathan Smith

In Depth 19 Apr 2022

How Augmented Reality Strengthens Biotech Manufacturing

Biotech and pharma companies are starting to implement augmented reality technologies at their manufacturing facilities, bringing forth a whole new world of possibilities. The Covid-19 pandemic has been a catalyst for embracing new ways of working. Travel restrictions and limited access to facilities have pushed the adoption of technologies that enhance remote work. This is […]

April 19, 2022 - 8 minutesmins - By Carlos de Rojas

Cultured meat Europe cellular agriculture

In Depth 13 Apr 2022

Cultured Meat Is Coming Soon: Here’s What You Need to Know

Cultured meat promises to change the way we eat and help solve some of the big problems of a crowded planet. When will it be on our plate and how will this technology impact the world? In a couple of years, your food might be served with meat that has been grown from animal cells […]

April 13, 2022 - 12 minutesmins - By Clara Rodríguez Fernández

finance top biotech investment March 2022

News and Trends 11 Apr 2022

The Top European Biotech Investments in March 2022

As wars and inflation buffet European markets, private biotech companies raised fewer investments in March 2022 than in previous months. The top private rounds went to firms developing cancer treatments and microbiome therapeutics. The first quarter of 2022 has seen a gradual decline of biotech investments in the European space. The total raised by European […]

April 11, 2022 - 5 minutesmins - By Jonathan Smith

UK kynos epidarex anti inflammatory drugs

News and Trends 8 Apr 2022

Epidarex Backs UK Startup Developing Emerging Anti-Inflammatory Drugs

The UK-US venture capitalist Epidarex Capital has led an €11M (£9M) funding round raised by the Edinburgh-based Kynos Therapeutics, which aims to develop anti-inflammatory treatments by blocking an emerging metabolic target. Much of the UK’s biotech innovation is concentrated in the so-called Golden Triangle, encompassing the hubs of Cambridge, Oxford, and London. In 2020, Epidarex […]

April 8, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 6 Apr 2022

Immunocore Approvals Open Door for TCR Cancer Drugs

The EU has followed the FDA in granting market approval to Kimmtrak, the first-ever bispecific drug based on a cancer-hunting protein called a T-cell receptor (TCR). These regulatory wins by the UK firm Immunocore pave the way for other treatments deploying TCRs. TCRs have become a hot topic in immuno-oncology. Many companies are developing cancer […]

April 6, 2022 - 3 minutesmins - By Jonathan Smith

world health organization genomics pathogen pandemic

News and Trends 5 Apr 2022

WHO Beefs up Worldwide Genomic Surveillance to Prevent Pandemics

The World Health Organization has released a 10-year plan to monitor the genetic make-up of pathogens across the globe. The strategy highlights how far genomics has come during the Covid-19 pandemic and how far there is to go. The past two years have seen unprecedented global collaboration as researchers raced to better understand the epidemiology, […]

April 5, 2022 - 4 minutesmins - By Anita Chakraverty

In Depth 4 Apr 2022

Portable Sequencing Is Reshaping Genetics Research

Portable sequencing is making it possible for biologists to perform DNA analysis anywhere in the world. How is this technology reshaping the way they work? Thanks to nanopore technology, scientists can now collect samples and sequence them anywhere. It is the concept of backpacking applied to scientific research. French molecular biologist Anne-Lise Ducluzeau has experienced […]

April 4, 2022 - 11 minutesmins - By Carlos de Rojas

News and Trends 1 Apr 2022

Europe Shuns Russian Covid-19 Vaccines as Ukraine War Continues

In the last two years, Russian Covid-19 vaccine makers had a tough time penetrating the European market with their flagship vaccine, Sputnik V. This year, Russia’s invasion of Ukraine has likely dashed Sputnik V’s chances of reaching Europe anytime soon. Just months after the Covid-19 pandemic began, Russia was the first country to approve a […]

April 1, 2022 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Forcefield Therapeutics Launched to Treat Heart Attacks with Protein Drugs

Cloud Computing Can Help Life Sciences Catch Up Before It’s Too Late

European Biotech Investors Brace for Volatility in 2022

Valneva’s Covid-19 Vaccine Reaches UK Market with EU In Sights

How Augmented Reality Strengthens Biotech Manufacturing

Cultured Meat Is Coming Soon: Here’s What You Need to Know

The Top European Biotech Investments in March 2022

Epidarex Backs UK Startup Developing Emerging Anti-Inflammatory Drugs

Immunocore Approvals Open Door for TCR Cancer Drugs

WHO Beefs up Worldwide Genomic Surveillance to Prevent Pandemics

Portable Sequencing Is Reshaping Genetics Research

Europe Shuns Russian Covid-19 Vaccines as Ukraine War Continues

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!